this study reports on the occurence of JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib / Pieri, Lisa; Pancrazzi, Alessandro; Pacilli, Annalisa; Rabuzzi, Claudia; Rotunno, Giada; Fanelli, Tiziana; Guglielmelli, Paola; Fjerza, Rajmonda; Paoli, Chiara; Verstovsek, Srdan; Vannucchi, Alessandro M. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 125:(2015), pp. 3352-3353. [10.1182/blood-2015-01-624536]
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
PIERI, LISA;PANCRAZZI, ALESSANDRO;PACILLI, ANNALISA;ROTUNNO, GIADA;FANELLI, TIZIANA;GUGLIELMELLI, PAOLA;FJERZA, RAJMONDA;PAOLI, CHIARA;VANNUCCHI, ALESSANDRO MARIA
2015
Abstract
this study reports on the occurence of JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Pieri_Blood_2015.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
499.43 kB
Formato
Adobe PDF
|
499.43 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.